Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Interferon Treatment Should Be Spread by Sharing Know-how
October 1, 2007
- Staff's Workload Must Be Reduced to Promote Clinical Trials at Univ. Hospitals: Mr Miura
October 1, 2007
- Chuikyo Recommends NHI Price Listing for 14 Products (9 APIs)
October 1, 2007
- Pharmacoeconomics Essential for Assessing Drugs: Dr Aoki
October 1, 2007
- REGULATORY NEWS IN BRIEF
October 1, 2007
- Survey：Survey Shows 90% of IBS Patients Not Aware They Have a Disease
October 1, 2007
- Combined Sales Up 13.8% for JGPMA Member Companies
October 1, 2007
- Primary Doctor System Proposed by Korosho Interferes with Patients' Free Access to Medical Services: JMA
October 1, 2007
- Nihon Medi-Physics, Nippon Kayaku to Handle Metastron of GE Healthcare
September 24, 2007
- Environment Assuring Rapid Supply of New Anticancer Drugs Needed
September 24, 2007
- NBI Moves Its Tokyo Office to Osaki
September 24, 2007
- Development of New PPAR Agonists Extremely Difficult: Dr Obayashi
September 24, 2007
- Innovex, So-net M3 to Provide MR Activities Assessing Service
September 24, 2007
- Need to Legalize GL on Clinical Research Stressed by Committee Members
September 24, 2007
- Kyowa Hakko Recalls Coniel Tab due to Contamination Problem
September 24, 2007
- R&D NEWS IN BRIEF
September 24, 2007
- BUSINESS NEWS IN BRIEF
September 24, 2007
- OPINION／Secrets behind a Winning Recruitment Team
September 24, 2007
- TOPICS／Banyu Most Often Comes to Mind for its Female MRs: Nextit Survey
September 24, 2007
- FY2007 Annual Report on Health and Welfare Published
September 24, 2007
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…